Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
November 17, 2020 11:30 am ETEstimated Read Time: 4 Minutes
Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. But this has failed in the past and could prevent measures from moving forward this time unless new research could be presented to sway the state medical board’s decision. The 34th largest state by area and the seventh most populated state in our country is Ohio, aka the Buckeye state. Ohio became the 25th state to legalize medical cannabis back on June 8 of 2016. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523.
Of the current 22 qualifying conditions to receive a legal recommendation for medical cannabis, opioid use disorder, Autism Spectrum Disorder, and anxiety are not on that list. Advocates have tried to make this happen in the past partitioning for the addition of these three conditions, but they were ultimately denied by the state’s medical review board.
Strict Guidelines Must be Met Before Conditions Will Be Considered
In regard to the petition to add these three conditions to state law, advocates must be very careful. According to the Ohio State Medical Marijuana website, the petition will not be considered if received after December 31, 2020, if it seeks to add a broad category of diseases or conditions, or if the condition is one that has been previously reviewed by the board and rejected unless new scientific research that supports the request is offered.
Since these conditions have been denied in the past, advocates must meet very specific guidelines to try to get them approved this time. The state website says,
“If you are petitioning for a previously considered condition, do not resubmit documents which have already been reviewed by the board, and only new scientific research should be submitted for previously rejected petitions.”
One Ohio Physician Embraces Cannabis Research But Denies Effectiveness
Back in 2019, it seemed as though advocates might have had things going in their favor to add Autism Spectrum Disorder and anxiety to this list of qualifying conditions. However, that forward momentum was short-lived. Several physicians gave their input and were the deciding factors in helping prevent the addition of these two conditions to the qualifying list. One, in particular, Dr. Anup Patel is the most perplexing.
Dr. Patel is a member of the Nationwide Children’s Hospital. He ran clinical trials for big pharma’s GW Pharmaceuticals research division on Epidiolex. Epidiolex is an FDA approved cannabis-based pharmaceutical manufactured drug used in the treatment of seizures. Yet Dr. Patel held the view that there is little to no gold standard research to prove cannabis effectively helps treat anxiety or Autism. It seems incredibly conflicting that a medical professional can lead research on cannabis medicine that finds FDA approval yet turn around and say that cannabis has no proof of being effective?
See If You Qualify For Medical Marijuana -Select Your State!
In the opinion of this writer, physicians like Dr. Patel are bought and paid for. It is maddening to see medical professionals clinging to the destructive addictive past of pharmaceuticals without open acceptance to plant medicine. It’s frustrating scenarios such as this that have contributed to the failed War on Drugs and have cost the United States countless billions of wasted tax dollars in the process.
Research Shows to be Supportive Despite it All
In fact, cannabis has shown potential in managing Autism. In October of 2019, just two months after Dr. Patel made his opinionated viewpoint about the lack of proof of effectiveness in cannabis to treat Autism, the US National Library of Medicine National Institutes of Health had a research paper published that suggested Dr. Patel was wrong.
The study is titled, “Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use” and is published on the NCBI. It revealed that,
“Overall, mostly positive outcomes were reported for the 15 patients that adhered to the standardized CE treatment (one case for six months and 14 cases for nine months), especially regarding improvements in sleep disorders, seizures, and behavioral crisis. Also, signs of improvement were reported for motor development, communication and social interaction, and cognitive performance.”
Maybe there were just enough lacking studies at the time for Dr. Patel to support denying the addition of Autism, anxiety, and opioid dependency to the list of qualifying conditions in Ohio. But here in 2020, that is not the case. Should the medical board in Ohio deny adding these conditions to the state’s list, it may be time to change who sits on this board. Last year Dr. Patel said, “the State Medical Board of Ohio is relying on traditional medicine.” Let’s see if this draconian stance is still supported this year and, if so, by who.
Ashley Priest is a patient, mother, entrepreneur, and activist that fights to end prohibition globally for a better future for all. Ashley has a passion for sharing education pertaining to the goddess plant known as cannabis. She believes that a single seed can tip the scales and that together through education we can end the stigma that is preventing cannabis from flowering to its full potential globally.
Have you ever consumed cannabis and gotten a little too high for your liking? Or have you ever needed to calm down a friend who consumed too much weed for their tolerance level? If so, we’ve got you covered. Although an overdose (taking more than what is medically recommended) of delta-9 tetrahydrocannabinol (THC) is not…
Cannabis tinctures are relatively new on the scene compared to the long, thousands-year-old history of the cannabis plant itself. It was first recognized for its medicinal use in European medicine in 1839, and by 1851, medicinal cannabis tinctures had made their way into a drug almanac known as the United States Pharmacopeia. Despite prohibition throughout…
When Piper Lindeen’s son Zach began showing medical issues at just three years old, no one suspected a rare, severe form of epilepsy. Doctors initially didn’t recognize his symptoms as seizures. Eventually, they diagnosed Zach with epilepsy—but by then, his condition had worsened from a few seizures a week to several each day. As it…
Though it may not be as widely discussed as other major health concerns like heart disease or cancer, liver disease is a common health condition that affects millions of people. According to the Centers for Disease Control and Prevention (CDC), there are currently 4.5 million adults who have been diagnosed with liver disease living in…
Over the years, Hollywood has had a mixed relationship with cannabis. Portrayals have run the gamut from weed as the devil’s lettuce, able to ruin your life and destroy your mind after just a single puff, to a beneficial, life-giving MacGuffin. Because American audiences have such wide-ranging attitudes towards weed— according to the Pew Research…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.